These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24813847)

  • 1. A case of nail psoriasis-associated psoriatic arthritis successfully treated with adalimumab.
    Ikumi N; Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Kuwana Y; Matsukawa Y; Hayama T; Sawada S; Takei M; Ochiai T
    Acta Dermatovenerol Croat; 2014; 22(1):65-6. PubMed ID: 24813847
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis.
    Wells LE; Evans T; Hilton R; Wine Lee L; Ruth N
    Pediatr Dermatol; 2019 May; 36(3):384-385. PubMed ID: 30811618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nail psoriasis with TNF-α or IL12/23 inhibitors.
    Jemec GB; Ibler KS
    J Drugs Dermatol; 2012 Aug; 11(8):939-42. PubMed ID: 22859238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid response to clinical symptoms in early psoriatic onycho-pachydermo-periostitis treated with infliximab.
    Horie K; Fujita Y; Hoshina D; Abe R; Shimizu H
    Australas J Dermatol; 2018 Feb; 59(1):e78-e79. PubMed ID: 28660645
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of inverse psoriasis successfully treated with adalimumab.
    Ješe R; Perdan-Pirkmajer K; Dolenc-Voljč M; Tomšič M
    Acta Dermatovenerol Alp Pannonica Adriat; 2014 Mar; 23(1):21-3. PubMed ID: 24638868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic uveitis responding to adalimumab therapy.
    Ermertcan AT; Emre S; Öztürk F; Gençoğlan G; Gündüz K
    Int J Dermatol; 2014 Apr; 53(4):e271-3. PubMed ID: 23879868
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis.
    Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677
    [No Abstract]   [Full Text] [Related]  

  • 11. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate.
    Ochiai T; Washio H; Shiraiwa H; Takei M; Sawada S
    Med Sci Monit; 2006 Apr; 12(4):CS27-30. PubMed ID: 16572055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.
    Shaw CA; Kole LCS; Elewski BE
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e431-e432. PubMed ID: 31220373
    [No Abstract]   [Full Text] [Related]  

  • 15. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
    Williamson L; Dalbeth N; Dockerty JL; Gee BC; Weatherall R; Wordsworth BP
    Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Crowley JJ; Weinberg JM; Wu JJ; Robertson AD; Van Voorhees AS;
    JAMA Dermatol; 2015 Jan; 151(1):87-94. PubMed ID: 25471223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis.
    Kimura U; Kinoshita A; Haruna K; Mizuno Y; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Mar; 39(3):286-7. PubMed ID: 21957978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.